Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemischer Name: N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-delta-acetyl-N-delta-benzoyloxy-L-ornithine // Synonyme: (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(N-(benzoyloxy)acetamido)pentanoic acid, Fmoc-Orn(Ac,Obz)-OH
Ab 650,00 €
The hydroxamate-ornithine derivative N-delta-hydroxy-N-delta-acetyl-ornithine is a bidentate ligand that is found in many siderophores, a Fe(III)-binding class of biomolecules that can be employed as siderophore-drug-conjugates (“Trojan Horse Strategy”). The N-alpha-Fmoc-N-delta-acetyl-N-delta-benzyloxycarbonyl-L-ornithine building block is suitable for SPPS. Moreover, the N-delta-group can be deprotected on-resin to liberate the native metal-ion-binding N-delta-hydroxy-N-delta-acetyl-motif. Conditions for on-resin N-delta-deprotection: 1 M LiOH in THF/MeOH (1:1)
Enterobactin-Mediated Delivery of ß-Lactam Antibiotics Enhances Antibacterial Activity against Pathogenic Escherichia coli; T. Zheng and E. M. Nolan; Journal of the American Chemical Society 2014; 136: 9677-9691. doi:10.1021/ja503911p Siderophore-Mediated Cargo Delivery to the Cytoplasm of Escherichia coli and Pseudomonas aeruginosa: Syntheses of Monofunctionalized Enterobactin Scaffolds and Evaluation of Enterobactin-Cargo Conjugate Uptake; T. Zheng, J. L. Bullock and E. M. Nolan; Journal of the American Chemical Society 2012; 134: 18388-18400 doi:10.1021/ja3077268 Exploiting bacterial iron acquisition: siderophore conjugates; C. Ji, R. E. Juarez-Hernandez and M. J. Miller; Future medicinal chemistry 2012; 4: 297-313. doi:10.4155/fmc.11.191
Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer; P. Ding, P. Helquist and M. J. Miller; Bioorganic & Medicinal Chemistry 2008; 16: 1648-1657. doi:http://dx.doi.org/10.1016/j.bmc.2007.11.030
Design and synthesis of a novel protected mixed ligand siderophore; P. Ding, C. E. Schous and M. J. Miller; Tetrahedron letters 2008; 49: 2306-2310. doi:10.1016/j.tetlet.2008.02.007
Bitte senden Sie mir mehr Informationen über